Childhood Reactive Thrombocytosis

Reactive thrombocytosis (RT) in pediatric patients is common, but usually without symptoms. The incidence of RT is different depending on age. Mostly, we reasoned that RT is a phenomenon, nevertheless the diagnostic value of RT is little known. Therefore, the aim of this study was to determine the association of RT and clinical or laboratory characteristics in pediatric diseases.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Reactive Thromobocytosis in Children

Age range

1 day–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Taipei Medical University-WanFang Hospital

Taipei, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The platelet counts more than 500x109/l and age less than 18 years old.

Exclusion criteria

repeated hospitalization ( more than 2 times)

Sponsors and collaborators

Lead sponsor

Taipei Medical University WanFang Hospital

Other

Registry information

Official study title

Childhood Reactive Thrombocytosis (RT)

Acronym: RT

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Oct 29, 2010
Registry last updated: Oct 29, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.